Office of the Chief Health and Medical Officer (OCHMO)

Office of the Chief Health and Medical Officer (OCHMO)
Astronauts
General
Human Health and Performance
Humans in Space
The Human Body in Space
In October 2024, NASA’s Office of the Chief Health and Medical Officer (OCHMO) initiated a working group to review the status and progress of research and clinical activities intended to mitigate the risk of venous thromboembolism (VTE) during spaceflight.
Posted March 15, 2025
Office of the Chief Health and Medical Officer (OCHMO)
Human Health and Performance
Humans in Space
The Human Body in Space
NASA’s Office of the Chief Health and Medical Officer (OCHMO) assembled a small working group to review hydrogen sulfide (H2S) Spacecraft Maximum Allowable Concentration (SMAC) values. The group met virtually three times during February and March 2023, and panel members submitted individual opinion statements in April 2023.
Posted January 17, 2025
Office of the Chief Health and Medical Officer (OCHMO)
Human Health and Performance
Humans in Space
International Space Station (ISS)
In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground
Posted December 31, 2024
Sign up for our newsletter:

Categories

1
Io
3
4
1
5
530
1
17
3
1
227
2
1
1
4
3
15
5
2
6
4
65
1
6
34
1
2
1
1
293
6
1
3
1
4
103
145
11
8
40
1
38
2
27
2
1
1
10
1
4
185
10
158
2
2
12
3
2
16
1
6
1
1
3
10
1
31
1
21
7

Recent Posts

Newsletter Archive